Konacc Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
as on 25-12-2024
- Paid Up Capital ₹ 3.87 M
as on 25-12-2024
- Company Age 16 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.42 M
as on 25-12-2024
- Satisfied Charges ₹ 1.80 Cr
as on 25-12-2024
- Revenue 39.21%
(FY 2022)
- Profit 39.54%
(FY 2022)
- Ebitda 33.72%
(FY 2022)
- Net Worth 21.15%
(FY 2022)
- Total Assets 36.20%
(FY 2022)
About Konacc Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 3.87 M.
The company currently has active open charges totaling ₹8.42 M. The company has closed loans amounting to ₹1.80 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kongara Srikanth and Kongara Swapnika serve as directors at the Company.
- CIN/LLPIN
U85110AP2008PTC061013
- Company No.
061013
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Sep 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Krishna, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Konacc Diagnostics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kongara Srikanth  | Managing Director | 12-Sep-2008 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kongara Swapnika | Director | 12-Sep-2008 | Current |
Financial Performance of Konacc Diagnostics.
Konacc Diagnostics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 39.21% increase. The company also saw a substantial improvement in profitability, with a 39.54% increase in profit. The company's net worth Soared by an impressive increase of 21.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Konacc Diagnostics?
In 2022, Konacc Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Coastal Endocrine Specialty Hospitals Private LimitedActive 12 years 6 monthsKongara Srikanth and Kongara Swapnika are mutual person
- Endolife Speciality Hospitals Private LimitedActive 11 years 6 months
Kongara Srikanth and Kongara Swapnika are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Dec 2023 | ₹2.92 M | Open |
State Bank Of India Creation Date: 27 Jul 2015 | ₹5.50 M | Open |
State Bank Of India Creation Date: 06 May 2011 | ₹1.80 Cr | Satisfied |
How Many Employees Work at Konacc Diagnostics?
Konacc Diagnostics has a workforce of 42 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Konacc Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Konacc Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
